About Serine/threonine-protein kinase Kist
Serine/threonine-protein kinase Kist (UHMK1) is a protein
from Homo sapiens identified by UniProt accession
Q8TAS1, 419 residues long.
MolForge cross-references it against 0 known binders and
71 disease associations.
Target properties
| Protein name | Serine/threonine-protein kinase Kist |
| UniProt accession | Q8TAS1 |
| Gene | UHMK1 |
| Organism | Homo sapiens |
| Length | 419 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (71)
Diseases linked to this target (Open Targets).
- Rare genetic intellectual disability with developmental anomaly · score 0.27
- neurodegenerative disease · score 0.24
- sitting height measurement · score 0.23
- lung adenocarcinoma · score 0.09
- blood protein measurement · score 0.08
- hepatocellular carcinoma · score 0.08
- melanoma · score 0.06
- schizophrenia · score 0.05
- neoplasm · score 0.04
- Combined hyperlipidemia · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8TAS1-F1 | alphafold | PREDICTED | 89.75 | — |
Amino-acid sequence (419 residues)
MAGSGCAWGA EPPRFLEAFG RLWQVQSRLG SGSSASVYRV RCCGNPGSPP GALKQFLPPG TTGAAASAAE YGFRKERAAL EQLQGHRNIV TLYGVFTIHF SPNVPSRCLL LELLDVSVSE LLLYSSHQGC SMWMIQHCAR DVLEALAFLH HEGYVHADLK PRNILWSAEN ECFKLIDFGL SFKEGNQDVK YIQTDGYRAP EAELQNCLAQ AGLQSDTECT SAVDLWSLGI ILLEMFSGMK LKHTVRSQEW KANSSAIIDH IFASKAVVNA AIPAYHLRDL IKSMLHDDPS RRIPAEMALC SPFFSIPFAP HIEDLVMLPT PVLRLLNVLD DDYLENEEEY EDVVEDVKEE CQKYGPVVSL LVPKENPGRG QVFVEYANAG DSKAAQKLLT GRMFDGKFVV ATFYPLSAYK RGYLYQTLL
Explore Serine/threonine-protein kinase Kist with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets